Pelaia, C.;                     Pelaia, G.;                     Crimi, C.;                     Maglio, A.;                     Gallelli, L.;                     Terracciano, R.;                     Vatrella, A.    
        Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. Int. J. Mol. Sci. 2021, 22, 4369.
    https://doi.org/10.3390/ijms22094369
    AMA Style
    
                                Pelaia C,                                 Pelaia G,                                 Crimi C,                                 Maglio A,                                 Gallelli L,                                 Terracciano R,                                 Vatrella A.        
                Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. International Journal of Molecular Sciences. 2021; 22(9):4369.
        https://doi.org/10.3390/ijms22094369
    
    Chicago/Turabian Style
    
                                Pelaia, Corrado,                                 Giulia Pelaia,                                 Claudia Crimi,                                 Angelantonio Maglio,                                 Luca Gallelli,                                 Rosa Terracciano,                                 and Alessandro Vatrella.        
                2021. "Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma" International Journal of Molecular Sciences 22, no. 9: 4369.
        https://doi.org/10.3390/ijms22094369
    
    APA Style
    
                                Pelaia, C.,                                 Pelaia, G.,                                 Crimi, C.,                                 Maglio, A.,                                 Gallelli, L.,                                 Terracciano, R.,                                 & Vatrella, A.        
        
        (2021). Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. International Journal of Molecular Sciences, 22(9), 4369.
        https://doi.org/10.3390/ijms22094369